Less-experienced surgeons experience a lower perioperative morbidity rate and sound early oncologic outcomes with robot-assisted laparoscopic radical prostatectomy, compared with other surgical ...

(HealthDay News) — From 2003–2010 there was widespread adoption of robot-assisted radical prostatectomy (RARP), especially among high-volume surgeons, according to a study published online August 26 ...

The first direct comparison between robot-assisted laparoscopic prostatectomy and open surgery (radical retropubic prostatectomy) has ended in a tie. Early results from an international, randomized, ...

Levee Medical®, a medical device company focused on improving outcomes for prostate cancer surgery patients, today announced continued progress in the clinical and commercial advancement of its Voro® ...

Dr. Khurshid Guru answers the question: 'Hospital Stay After Prostatectomy?' March 16, 2009 -- Question: How long will I be in the hospital following my radical laparoscopic, perineal, or retropubic ...

Double-Blind, Randomized Trial of Docetaxel Plus Vandetanib Versus Docetaxel Plus Placebo in Platinum-Pretreated Metastatic Urothelial Cancer Completed surveys were obtained from 685 (86%) of 797 ...

At 24 months' follow-up, the only phase 3 randomized clinical trial to directly compare functional and oncologic outcomes between robot-assisted laparoscopic prostatectomy and open radical retropubic ...

Patients who underwent robot-assisted radical prostatectomy and were discharged the same day had complication and 90-day readmission rates similar to those who had the procedure as inpatients.

Comorbid Diseases Lessen Survival Benefit of Aggressive PCa Therapy Growth in robot-assisted radical prostatectomy (RARP) use especially pronounced among surgeons at urban hospitals. Robot-assisted ...

FDG-PET as a predictive marker for therapy with everolimus in metastatic renal cell cancer (mRCC). Clinical experience of docetaxel in combination with prednisolone and zoledronic acid for ...